Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when PL files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: PL Planet Labs PBC 8-K

Planet Labs calls all outstanding public warrants for redemption

Filed March 27, 2026 · Period ending March 27, 2026 · ~1 min read

3 key changes 1 high relevance 2 sections

Key Changes

  • high

    Planet Labs is redeeming all public warrants issued in its 2021 IPO that allow holders to buy Class A common stock. Warrant holders must act by the redemption deadline or lose their rights.

  • medium

    The redemption is being conducted under the original warrant agreement with Continental Stock Transfer & Trust Company. Specific redemption price and deadline are in the notice of redemption (Exhibit 99.2).

    8-K: Warrant Agreement verify on EDGAR →
  • medium

    Company issued press release on March 27, 2026 announcing the warrant redemption. Full details available in Exhibit 99.1.

Summary

Planet Labs announced it is calling for redemption all outstanding public warrants that were issued as part of its 2021 initial public offering. These warrants give holders the right to purchase Class A common stock at a set price. The redemption follows the terms of the original warrant agreement signed with Continental Stock Transfer & Trust Company.

For retail investors, this matters if you hold Planet Labs warrants. You'll need to decide whether to exercise them before the redemption deadline (buying shares at the warrant price) or let them be redeemed for likely a nominal amount. The company's decision to redeem suggests management believes the current stock price makes it advantageous to force warrant holders to either exercise or forfeit their rights.

Watch for the stock price reaction and any insider trading activity around the redemption date. If the stock trades well above the warrant exercise price, this could bring in cash to the company while increasing share count. Check Exhibit 99.2 for the exact redemption date and terms.

Section-by-Section Diff

Event · Item 8.01 — Other Events

~200 words

Item 8.01 — Other Events filed; see Key Changes for terms.

1 Added
Added Warrant redemption medium

Added in current filing · verify on EDGAR →

On March 27, 2026, Planet Labs PBC (the “Company”) issued a press release announcing the redemption of all of its outstanding public warrants to purchase shares of the Company’s Class A common stock that were issued under the Warrant Agreement, dated March 4, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agreement”), as part of the units sold in the Company’s initial public offering.

The company is redeeming all outstanding public warrants that allow holders to purchase Class A common stock. These warrants were originally issued as part of the units sold in the company's initial public offering in 2021. The redemption is being conducted under the terms of the existing warrant agreement with Continental Stock Transfer & Trust Company as warrant agent.

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

Planet Labs PBC filed an 8-K disclosing a press release and notice of redemption dated March 27, 2026.

2 Added
Added Notice of Redemption high

Added in current filing · verify on EDGAR →

Notice of Redemption, dated March 27, 2026

Planet Labs PBC has issued a notice of redemption dated March 27, 2026. The 8-K does not include the full text of the notice, so the specific securities being redeemed, redemption price, and redemption date are not disclosed in this filing. Investors should review Exhibit 99.2 for complete redemption terms.

Added Press Release medium

Added in current filing · verify on EDGAR →

Press Release of Planet Labs PBC, dated March 27, 2026

Planet Labs PBC issued a press release on March 27, 2026. The 8-K does not include the full text of the press release, so the specific content and subject matter are not disclosed in this filing. Investors should review Exhibit 99.1 for details.

Was this report useful?